TR100 100mg*10vials

Tirzepatide TR100 100mg*10vials

Tirzepatide is a dual GLP-1 and GIP receptor agonist peptide, representing the highest-concentration metabolic research compound in the tirzepatide product line.

The 100mg single-vial specification delivers the maximum active ingredient load available. This premium formulation is designed for ultra-long-term large animal models, extreme high-dose gradient experiments, and the largest-scale multi-group parallel research projects. The exceptionally high concentration per vial eliminates repeated dilution steps across very long experimental timelines, effectively reducing data deviation and operational errors from frequent solution preparation.

Through combined GLP-1 and GIP receptor activation, this compound supports comprehensive research into insulin sensitivity, glycemic regulation, appetite-related signaling, and metabolic homeostasis. The dual pathway approach provides full-spectrum metabolic regulation research coverage under maximum-dose experimental conditions.

This product is supplied as sterile lyophilized powder in glass vials, formulated for reconstitution with bacteriostatic water. Every batch undergoes comprehensive purity testing, with a full certificate of analysis provided.

10 vials per pack, designed for top-tier professional research institutions and large-scale global wholesale procurement.